News

A sweeping change is underway in the diagnosis and treatment of traumatic brain injury (TBI), as experts worldwide introduce the CBI-M framework—a multidimensional system designed to provide a far more detailed and individualized understanding of each patient’s condition.

In a remarkable leap forward for neuro-oncology, scientists in the UK have unveiled a pioneering diagnostic tool that dramatically cuts the waiting time for brain tumour classification — from the current six to eight weeks down to just two hours. This new test, called ROBIN (Rapid Nanopore Brain Intraoperative Classification), promises to transform both surgical decision-making and patient care.

In a landmark achievement for precision medicine, researchers have successfully used personalized gene editing to treat an infant suffering from carbamoyl phosphate synthetase 1 (CPS1) deficiency, a rare and life-threatening genetic disorder.

A recent study published in JAMA Network Open has revealed that preterm infants born to mothers affected by preeclampsia show early signs of brain injury, leading to impaired neurodevelopment by age two.

{noindex} Amsterdam, April 29, 2025 — A new study published in The Lancet Regional Health – Europe reveals that researchers at Amsterdam UMC have developed a fast, affordable diagnostic test to detect bacterial meningitis with high accuracy using C-reactive protein (CRP) levels in cerebrospinal fluid (CSF).

A groundbreaking study offers fresh insight into the biological underpinnings of autism spectrum disorder (ASD), using a rare neuromuscular disease as a model to illuminate critical pathways in brain development.

Emerging research suggests that cannabidiol (CBD) extract may offer meaningful benefits for children and adolescents with autism spectrum disorder (ASD), according to a meta-analysis presented at the European Psychiatric Association (EPA) Congress 2025.

Mass General Brigham researchers, in collaboration with Boston Children’s Hospital and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, have unveiled a promising advance in pediatric brain tumor care: